Pathobiochemistry and clinical use of procalcitonin (Q34756556)

4 August 2017

1 reference

title

Pathobiochemistry and clinical use of procalcitonin. (English)

1 reference

4 August 2017

Michael Meisner

1

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

323

1 reference

4 August 2017

1-2

1 reference

4 August 2017

17-29

1 reference

High serum procalcitonin concentrations in patients with sepsis and infection

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin and CGRP-1 mrna expression in various human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

CD26, let it cut or cut it down.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Late pulmonary sequela following burns: persistence of hyperprocalcitonemia using a 1-57 amino acid N-terminal flanking peptide assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin is not produced by circulating blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Calcitonin gene expression in normal human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Serum procalcitonin as an index of inhalation injury in burns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin and proinflammatory cytokine interactions in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Disordered calcium homeostasis of sepsis: association with calcitonin precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Pneumonitis-associated hyperprocalcitoninemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Serum procalcitonin concentrations in acute malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Serum ionized calcium, serum and intracellular phosphate, and serum parathormone concentrations in acute malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Postoperative plasma concentrations of procalcitonin after different types of surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin: a valuable indicator of infection in a medical ICU?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

APACHE II: a severity of disease classification system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin and C-reactive protein levels in neonatal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin as a marker of severity in septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Measurement of Procalcitonin Levels in Children with Bacterial or Viral Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Serum procalcitonin levels in bacterial and abacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin in children admitted to hospital with community acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin used as a marker of infection in the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Molecular aspects and natural source of procalcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Procalcitonin in early detection of postoperative complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900101-8

10.1016/S0009-8981(02)00101-8

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12135804